Cargando…
Kinetics of humoral deficiency in CART19-treated children and young adults with acute lymphoblastic leukaemia
CD19-CAR T-cell therapy (CART19) causes B-cell aplasia (BCA) and dysgammaglobulinemia but there is a lack of information about the degree of its secondary immunodeficiency. We conducted a prospective study in children and young adults with acute lymphoblastic leukaemia treated with CART19, analysing...
Autores principales: | Deyà-Martínez, A., Alonso-Saladrigues, A., García, A. P., Faura, A., Torrebadell, M., Vlagea, A., Català, A., Esteve-Solé, A., Juan, M., Rives, S., Alsina, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870804/ https://www.ncbi.nlm.nih.gov/pubmed/32801317 http://dx.doi.org/10.1038/s41409-020-01027-6 |
Ejemplares similares
-
Risk factors and outcome of Chimeric Antigen Receptor T-Cell patients admitted to Pediatric Intensive Care Unit: CART-PICU study
por: Caballero-Bellón, Marina, et al.
Publicado: (2023) -
Factors associated with the clinical outcome of patients with relapsed/refractory CD19(+) acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
por: Ortiz-Maldonado, Valentín, et al.
Publicado: (2021) -
B Regulatory Cells: Players in Pregnancy and Early Life
por: Esteve-Solé, Ana, et al.
Publicado: (2018) -
Toll-like receptor 3 deficiency in autoimmune encephalitis post–herpes simplex encephalitis
por: Armangue, Thaís, et al.
Publicado: (2019) -
COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era
por: Deyà-Martínez, A., et al.
Publicado: (2021)